Naveen Pemmaraju: Recognizing MPN Awareness Day

Naveen Pemmaraju shared a post on LinkedIn:

“Recognizing MPN Awareness Day today!

Dedicated to all of our patients and caregivers and families facing MPNs around the world and to our prolific researchers and health care providers focusing on MPNs.”

Source: Naveen Pemmaraju/LinkedIn

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.

His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.